Clenbuterol 40mcg NOVUS

Trade Names: Clen, Ventipulmin

Chemical Names: Clenbuterol Hydrochloride

Routes: Oral, Injectable

Clenbuterol 40mcg NOVUS  is a sympathomimetic amine and a β2β2​ agonist originally developed as a bronchodilator for respiratory conditions. In the context of weightloss , it is utilized for its potent thermogenic properties and its ability to accelerate the breakdown of triglycerides into free fatty acids.

Key Physiological Effects

• Thermogenesis: Increases core body temperature (typically by 0.5∘C0.5∘C to 1∘C1∘C), which signals an elevated basal metabolic rate (BMR).
• Aerobic Capacity: Enhances oxygen transportation and central nervous system activity.
• Fat Metabolism: Stimulates fat cells to increase the rate of lipolysis.

Dosage and Administration

Careful titration is required to mitigate severe side effects.

• Initial Dosage: 30–40 mcg30–40 mcg per day.
• Progression: Increase by 10–20 mcg10–20 mcg every 3–4 days as tolerated.
• Maximum Limits: Never exceed 120 mcg120 mcg per day for men or 80 mcg80 mcg per day for women.

Receptor Management

The efficacy of Clenbuterol for weightloss typically diminishes after 4–6 weeks due to the down-regulation of β2β2​ receptors.

• Monitoring: Effectiveness can be tracked by measuring resting body temperature early in the morning.
• Ketotifen: To prevent receptor down-regulation, 3 mg3 mg of Ketotifen (an antihistamine) may be taken daily, allowing for extended use without the traditional 2-week "on/off" cycle.

Risks and Safety

Clenbuterol is a potent CNS stimulant with a significant potential for toxicity. Abuse or rapid escalation of dosages has been linked to severe cardiac issues and fatalities.